Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 6.59M | € 4.69M | € 9.43M | € 31.92M | € 7.68M |
Total Assets | € 202.67M | € 140.00M | € 146.32M | € 169.30M | € 123.93M |
Total Debt | € 57.97M | € 8.57M | € 39.74M | € 35.69M | € 37.41M |
Net Debt | € 51.38M | € 3.88M | € 30.31M | € 3.77M | € 29.73M |
Total Liabilities | € 98.47M | € 96.03M | € 101.48M | € 138.38M | € 96.34M |
Stockholders Equity | € 104.17M | € 43.96M | € 44.83M | € 30.91M | € 27.57M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |